Ping Mu

Affiliations: 
University of Texas Southwestern Medical Center, Dallas, TX, United States 
Area:
Cancer Biology
Google:
"Ping Mu"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

He X, Han Z, Yin H, et al. (2021) High-Throughput Sequencing-Based Identification of miRNAs and Their Target mRNAs in Wheat Variety Qing Mai 6 Under Salt Stress Condition. Frontiers in Genetics. 12: 724527
Lu F, Zhu L, Jia X, et al. (2021) Downregulated in renal carcinoma 1 (DRR1) mediates the differentiation of neural stem cells through transcriptional regulation. Neuroscience Letters. 135943
Lu F, Zhu L, Mu B, et al. (2021) Down-regulated in renal cell carcinoma 1 (DRR1) regulates axon outgrowth during hippocampal neuron development. Biochemical and Biophysical Research Communications. 558: 36-43
Zhu L, Lu F, Jia X, et al. (2021) Amyloid-β (25-35) regulates neuronal damage and memory loss via SIRT1/Nrf2 in the cortex of mice. Journal of Chemical Neuroanatomy. 101945
Blatt EB, Kopplin N, Kumar S, et al. (2020) Overcoming oncogene addiction in breast and prostate cancers: a comparative mechanistic overview. Endocrine-Related Cancer
Zhang K, Guan J, Mu P, et al. (2020) Visible and near-infrared driven Yb/Tm co-doped InVO nanosheets for highly efficient photocatalytic applications. Dalton Transactions (Cambridge, England : 2003). 49: 14030-14045
Li Y, Wang S, Dong Y, et al. (2020) Effect of size and crystalline phase of TiO nanotubes on cell behaviors: A high throughput study using gradient TiO nanotubes. Bioactive Materials. 5: 1062-1070
Zhang Z, Karthaus WR, Lee YS, et al. (2020) Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer. Cancer Cell
Zhang Z, Zhou C, Li X, et al. (2020) Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation. Cancer Cell
Lu F, Cui D, Mu B, et al. (2020) Downregulation of TMOD1 promotes cell motility and cell proliferation in cervical cancer cells. Oncology Letters. 19: 3339-3348
See more...